U.S. Markets close in 2 hrs 59 mins

ContraVir’s stock suffers record plunge after seesaw week of upbeat drug studies, mistaken filings and withdrawals of withdrawals

Tomi Kilgore
ContraVir’s stock suffers record plunge after seesaw week of upbeat drug studies, mistaken filings and withdrawals of withdrawals

Shares of ContraVir Pharmaceuticals Inc. suffered a record Tuesday, to cap off a whipsaw week for investors that included upbeat results of a drug study, filings indicating the withdrawal, and a withdrawal of the withdrawal, of a share offering.